Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04429542
Title	Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Bicara Therapeutics
Indications	chordoma stomach cancer pancreatic cancer lung squamous cell carcinoma hepatocellular carcinoma ovary epithelial cancer colorectal cancer anal canal squamous cell carcinoma anaplastic thyroid carcinoma uveal melanoma head and neck squamous cell carcinoma triple-receptor negative breast cancer glioblastoma Advanced Solid Tumor
Therapies	BCA101 BCA101 + Pembrolizumab
Age Groups:	adult \| senior
Covered Countries	USA \| CAN \| AUS